Sunday, December 25, 2016 2:28:25 PM
The new patentable idea may be on a microscopic level. Many levels of variations that are already known can not be patented because it is common knowledge. One company may have a patent on a new drug or delivery system of a common drug. It may be that the drug naturally found in marijuana is only in need of a revolutionary delivery system that could get a patent. If OWCP patents, given that they are granted and issued, are better ideas that the competitions patented ideas, the market will buy it. The market will buy the better idea. The patent is only for the protection of the new idea. Drug companies fight over this.
I take comfort in knowing that two big distributors chose to give OWCP $600,000 ($300K each) in exchange for royalties or shares (some shares priced at .25 and .40 cents while current price was around 10 cents). These companies would not be so generously investing in OWCP if they didn't like what they are seeing. All that being said, it looks like the patents that OWCP are well worth investing in. Teva Pharmaceuticals is one of the largest drug manufacturers in the world and they expressed interest in the Patents owned by OWCP.
Read the PR page... http://www.owcpharma.com/press-releases/
This is specifically concerning Teva and the validity of OWCP patents... https://cannabislobby.wordpress.com/2015/07/28/teva-pharmaceutical-industries-looks-to-acquire-medical-marijuana-patents/
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM